Long-term coffee consumption and risk of cardiovascular disease: A systematic review and a dose-response meta-analysis of prospective cohort studies

Circulation

Volumn 129, Issue 6, 2014, Pages 643-659

  Ding, Ming ^a   Bhupathiraju, Shilpa N ^a   Satija, Ambika ^a   Van Dam, Rob M ^a,b   Hu, Frank B ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular diseases; Coffee; Meta analysis

Indexed keywords

CARDIOVASCULAR DISEASES; COFFEE; META-ANALYSIS;

CARDIOVASCULAR DISEASES; COFFEE; CORONARY DISEASE; HEART FAILURE; HUMANS; NONLINEAR DYNAMICS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84893858012     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.005925     Document Type: Article

References (73)

1. Paul O, Lepper MH, Phelan WH, Dupertuis GW, Macmillan A, McKean H, Park H. A longitudinal study of coronary heart disease. Circulation. 1963;28:20-31.
2. Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, Oates JA. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298:181-186.
3. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF. The arrhythmogenic effects of caffeine in human beings. N Engl J Med. 1983;308:814-816.
4. Thelle DS, Heyden S, Fodor JG. Coffee and cholesterol in epidemiological and experimental studies. Atherosclerosis. 1987;67:97-103.
5. Bak AA, Grobbee DE. The effect on serum cholesterol levels of coffee brewed by filtering or boiling. N Engl J Med. 1989;321:1432-1437.
6. Coffee drinking and acute myocardial infarction: report from the Boston Collaborative Drug Surveillance Program. Lancet. 1972;2:1278-1281.
7. Jick H, Miettinen OS, Neff RK, Shapiro S, Heinonen OP, Slone D. Coffee and myocardial infarction. N Engl J Med. 1973;289:63-67.
8. Hennekens CH, Drolette ME, Jesse MJ, Davies JE, Hutchison GB. Coffee drinking and death due to coronary heart disease. N Engl J Med. 1976;294:633-636.
9. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J. 1994;72:269-275.
10. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology. 1993;4:366-374.
11. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366:1891-1904.
12. Kokubo Y, Iso H, Saito I, Yamagishi K, Yatsuya H, Ishihara J, Inoue M, Tsugane S. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan Public Health Center-Based Study Cohort. Stroke. 2013;44:1369-1374.
13. Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R, Boeing H. Coffee consumption and risk of chronic disease in the European Prospective Investigation Into Cancer and Nutrition (EPIC)-Germany study. Am J Clin Nutr. 2012;95:901-908.
14. Sofi F, Conti AA, Gori AM, Eliana Luisi ML, Casini A, Abbate R, Gensini GF. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2007;17:209-223.
15. Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol. 2011;174:993-1001.
16. Mostofsky E, Rice MS, Levitan EB, Mittleman MA. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail. 2012;5:401-405.
17. Sugiyama K, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Ohmori-Matsuda K, Shimazu T, Nagai M, Sugawara Y, Hozawa A, Fukao A, Tsuji I. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140:1007-1013.
18. De Koning Gans JM, Uiterwaal CS, Van Der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, Beulens JW. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30:1665-1671.
19. Le Grady D, Dyer AR, Shekelle RB, Stamler J, Liu K, Paul O, Lepper M, Shryock AM. Coffee consumption and mortality in the Chicago Western Electric Company study. American Journal of Epidemiology. 1987;126:803-812.
20. Larsson SC, Virtamo J, Wolk A. Coffee consumption and risk of stroke in women. Stroke. 2011;42:908-912.
21. Martin JB, Annegers JF, Curb JD, Heyden S, Howson C, Lee ES, Lee M. Mortality patterns among hypertensives by reported level of caffeine consumption. Preventive Medicine. 1988;17:310-320.
22. Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, La Vecchia C, Tavani A. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28:527-539.
23. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. The New England Journal of Medicine. 1990;323:1026-1032.
24. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
25. Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ. 1990;300:566-569.
26. Wells G A S B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. www.ohri.ca/programs/clinical-epidemiology/oxford.asp. 2011. Accessed August 12, 2013.
27. Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: Findings from the primary prevention study. Journal of Internal Medicine. 1991;230:67-71.
28. Hedges L V T E, Johnson MC. Robust variance estimation in meta-regression with dependent effect size estimates. Research Synthesis Methods. 2010;1:39-65.
29. Klag MJ, Mead LA, La Croix AZ, Wang NY, Coresh J, Liang KY, Pearson TA, Levine DM. Coffee intake and coronary heart disease. Annals of Epidemiology. 1994;4:425-433.
30. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301-1309.
31. Gyntelberg F, Hein HO, Suadicani P, Sorensen H. Coffee consumption and risk of ischaemic heart disease-a settled issue? Journal of Internal Medicine. 1995;237:55-61.
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
33. Hart C, Smith GD. Coffee consumption and coronary heart disease mortality in Scottish men: A 21 year follow up study. Journal of Epidemiology and Community Health. 1997;51:461-462.
34. Wilhelmsen L, Tibblin G, Elmfeldt D, Wedel H, Werkö L. Coffee consumption and coronary heart disease in middle-aged Swedish men. Acta Med Scand. 1977;201:547-552.
35. Hakim AA, Ross GW, Curb JD, Rodriguez BL, Burchfiel CM, Sharp DS, Yano K, Abbott RD. Coffee consumption in hypertensive men in older middle-age and the risk of stroke: The Honolulu heart program. Journal of Clinical Epidemiology. 1998;51:487-494.
36. Klatsky AL, Friedman GD, Armstrong MA. Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. Am J Epidemiol. 1990;132:479-488.
37. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish heart health study follow up: Conflicting relations with coronary risk factors, coronary disease, and all cause mortality. Journal of Epidemiology and Community Health. 1999;53:481-487.
38. Lindsted KD, Kuzma JW, Anderson JL. Coffee consumption and causespecific mortality: association with age at death and compression of mortality. J Clin Epidemiol. 1992;45:733-742.
39. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Archives of Internal Medicine. 2000;160:3393-3400.
40. Bidel S, Hu G, Qiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia. 2006;49:2618-2626.
41. Jazbec A, Simic D, Corovic N, Durakovic Z, Pavlovic M. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. Journal of Health, Population, and Nutrition. 2003;21:332-340.
42. Greenberg JA, Dunbar CC, Schnoll R, Kokolis R, Kokolis S, Kassotis J. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr. 2007;85:392-398.
43. Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. The Journal of Nutrition. 2004;134:2381-2386.
44. Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ, Wang CL, Chen YM. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009;137:216-225.
45. Lopez-Garcia E, Van Dam RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, Rexrode KM, Hu FB. Coffee consumption and coronary heart disease in men and women: A prospective cohort study. Circulation. 2006;113:2045-2053.
46. Liu J, Sui X, Lavie CJ, Hebert JR, Earnest CP, Zhang J, Blair SN. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88:1066-1074.
47. Andersen LF, Jacobs DR, Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa women's health study. The American Journal of Clinical Nutrition. 2006;83:1039-1046.
48. Van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005;294:97-104.
49. Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Marchioli R, Investigators GI-P. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: Results from the Gissi (Gruppo Italiano per lo Studio Della Sopravvivenza Nell'infarto Miocardico)-prevenzione trial. Circulation. 2007;116:2944-2951.
50. Williams CJ, Fargnoli JL, Hwang JJ, Van Dam RM, Blackburn GL, Hu FB, Mantzoros CS. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care. 2008;31:504-507.
51. Greenberg JA, Chow G, Ziegelstein RC. Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham study). The American Journal of Cardiology. 2008;102:1502-1508.
52. Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr. 1999;53:831-839.
53. Happonen P, Laara E, Hiltunen L, Luukinen H. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. The British Journal of Nutrition. 2008;99:1354-1361.
54. Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113-1126.
55. Larsson SC, Mannisto S, Virtanen MJ, Kontto J, Albanes D, Virtamo J. Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke: A Journal of Ccerebral Circulation. 2008;39:1681-1687.
56. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51:83-133.
57. Mukamal KJ, Hallqvist J, Hammar N, Ljung R, Gemes K, Ahlbom A, Ahnve S, Janszky I. Coffee consumption and mortality after acute myocardial infarction: The Stockholm heart epidemiology program. American Heart Journal. 2009;157:495-501.
58. Karatzis E, Papaioannou TG, Aznaouridis K, Karatzi K, Stamatelopoulos K, Zampelas A, Papamichael C, Lekakis J, Mavrikakis M. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure? Int J Cardiol. 2005;98:425-430.
59. Ahmed HN, Levitan EB, Wolk A, Mittleman MA. Coffee consumption and risk of heart failure in men: An analysis from the cohort of Swedish men. American Heart Journal. 2009;158:667-672.
60. Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, Vamvakou G, Lekakis JP, Mavrikakis ME. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond). 2005;109:55-60.
61. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, Van Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009;119:1116-1123.
62. Zhang Z, Hu G, Caballero B, Appel L, Chen L. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr. 2011;93:1212-1219.
63. Leurs LJ, Schouten LJ, Goldbohm RA, Van Den Brandt PA. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands cohort study. The British Journal of Nutrition. 2010;104:1212-1221.
64. Verhoef P, Pasman WJ, Van Vliet T, Urgert R, Katan MB. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr. 2002;76:1244-1248.
65. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A, Group JS. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. Journal of Epidemiology and Community Health. 2011;65:230-240.
66. Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr. 2001;73:532-538.
67. Rautiainen S, Levitan EB, Orsini N, Akesson A, Morgenstern R, Mittleman MA, Wolk A. Total antioxidant capacity from diet and risk of myocardial infarction: A prospective cohort of women. The American Journal of Medicine. 2012;125:974-980.
68. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997;17:305-324.
69. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles X, Campos H. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology. 2006;17:506-511.
70. Selb Semerl J, Selb K. Coffee and alcohol consumption as triggering factors for sudden cardiac death: case-crossover study. Croat Med J. 2004;45:775-780.
71. Mostofsky E, Schlaug G, Mukamal KJ, Rosamond WD, Mittleman MA. Coffee and acute ischemic stroke onset: the Stroke Onset Study. Neurology. 2010;75:1583-1588.
72. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295:1135-1141.
73. Cornelis MC, Monda KL, Yu K, Paynter N, Azzato EM, Bennett SN, Berndt SI, Boerwinkle E, Chanock S, Chatterjee N, Couper D, Curhan G, Heiss G, Hu FB, Hunter DJ, Jacobs K, Jensen MK, Kraft P, Landi MT, Nettleton JA, Purdue MP, Rajaraman P, Rimm EB, Rose LM, Rothman N, Silverman D, Stolzenberg-Solomon R, Subar A, Yeager M, Chasman DI, Van Dam RM, Caporaso NE. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet. 2011;7:e1002033.